Literature DB >> 9565394

Prevalence of domestic violence in an inpatient female population.

K C McKenzie1, R B Burns, E P McCarthy, K M Freund.   

Abstract

Studies have evaluated the prevalence of domestic violence in populations of patients in emergency and primary care settings, but there are little data on patients admitted to hospitals. We undertook a study to evaluate the prevalence of domestic violence among female inpatients. Of 131 consecutive female patients between the ages of 18 and 60 admitted to a nontrauma urban teaching hospital asked to complete a self-administered survey about domestic violence, 101 completed the questionnaire. Twenty-six percent of the respondents reported being in an abusive relationship at one time. Two patients felt that domestic violence contributed to their current reason for admission. No respondents were asked about domestic violence by health care providers. Domestic violence is an uncommon but important precipitant to nontrauma hospital admissions. Physicians should query all female inpatients about domestic assault.

Entities:  

Mesh:

Year:  1998        PMID: 9565394      PMCID: PMC1496944          DOI: 10.1046/j.1525-1497.1998.00081.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  3 in total

1.  The Voices of survivors documentary: using patient narrative to educate physicians about domestic violence.

Authors:  Christina Nicolaidis
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

2.  Utility of STaT for the identification of recent intimate partner violence.

Authors:  Anuradha Paranjape; Kimberly Rask; Jane Liebschutz
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

3.  Evaluation of a women's safe shelter experience to teach internal medicine residents about intimate partner violence. A randomized controlled trial.

Authors:  Rebecca S Brienza; Laura Whitman; Lynnea Ladouceur; Michael L Green
Journal:  J Gen Intern Med       Date:  2005-06       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.